Verrica Pharmaceuticals Inc. (VRCA) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 17.18M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 17.18M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 17.18M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 17.18M | (m) | (m) |
| 2026-03-31 | 17.18M | (m) | (m) |
| 2025-12-31 | 17.18M | (m) | (m) |
| 2025-09-30 | 9.49M | (m) | (m) |
| 2025-06-30 | 9.45M | (m) | (m) |
| 2025-03-31 | 92.49M | (m) | (m) |
| 2024-12-31 | 91.78M | (m) | (m) |
| 2024-09-30 | 45.60M | (m) | (m) |
| 2024-06-30 | 42.67M | (m) | (m) |
| 2024-03-31 | 42.42M | (m) | (m) |
| 2023-12-31 | 42.42M | (m) | (m) |
| 2023-09-30 | 42.06M | (m) | (m) |
| 2023-06-30 | 42.06M | (m) | (m) |
| 2023-03-31 | 41.96M | (m) | (m) |
| 2022-12-31 | 41.85M | (m) | (m) |
| 2022-09-30 | 41.09M | (m) | (m) |
| 2022-06-30 | 41.09M | (m) | (m) |
| 2022-03-31 | 27.52M | (m) | (m) |
| 2021-12-31 | 27.52M | (m) | (m) |
| 2021-09-30 | 27.52M | (m) | (m) |
| 2021-06-30 | 27.51M | (m) | (m) |
| 2021-03-31 | 27.41M | (m) | (m) |
| 2020-12-31 | 25.44M | (m) | (m) |
| 2020-09-30 | 25.87M | (m) | (m) |
| 2020-06-30 | 25.81M | (m) | (m) |
| 2020-03-31 | 25.81M | (m) | (m) |
| 2019-12-31 | 25.81M | (m) | (m) |
| 2019-09-30 | 25.78M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |